Skip to content
2000
Volume 22, Issue 2
  • ISSN: 1573-3998
  • E-ISSN: 1875-6417

Abstract

Introduction/Objectives

Owing to the existing evidence of the implication of oxidative stress in the pathophysiology of type 2 diabetes mellitus (T2DM), the present study aims to investigate the correlation of serum total antioxidant status (TAS) with comorbidities, various biochemical parameters, and duration of T2DM. Various factors contributing to disease prevalence and trends in other biochemical parameters are assessed.

Methods

A retrospective observational study of 246 patients with T2DM whose data were retrieved from the Proficiency Health Diagnostic Lab System in Al Ain. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) program.

Results and Discussion

The prevalence of T2DM was found to be higher in gender (male), age (≥45 years), ethnicity (Middle Eastern), BMI (≥25), family history, and metabolic syndrome (hypertension and dyslipidemia). TAS was found to be significantly higher in patients with comorbidities, than in those without, particularly dyslipidemia and micro-albuminuria (<0.05). TAS was weakly positively correlated with various T2DM biochemical parameters (<0.05), except for Fasting blood glucose (FBG) (=0.061). TAS was weakly negatively correlated with BMI (≥25) (=0.042). Albumin-to-creatinine ratio (ACR) was statistically higher in hypertensives than normotensives (=0.049). Duration of disease was only significantly correlated with ACR (=0.325, =0.001). Uric acid levels were statistically higher in patients with microalbuminuria than in patients without microalbuminuria (=0.001).

Conclusion

TAS was higher in patients with dyslipidemia and microalbuminuria, suggesting the influence of other factors such as uric acid and lipid-lowering agents. TAS could be an important factor in the management of T2DM cases. This needs to be further investigated in future studies to fill the gap found in the literature.

This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998336940241219182916
2025-01-09
2026-02-20
Loading full text...

Full text loading...

/deliver/fulltext/cdr/22/2/CDR-22-2-08.html?itemId=/content/journals/cdr/10.2174/0115733998336940241219182916&mimeType=html&fmt=ahah

References

  1. GuptaS. SharmaN. AroraS. VermaS. Diabetes: A review of its pathophysiology, and advanced methods of mitigation.Curr. Med. Res. Opin.202440577378010.1080/03007995.2024.233344038512073
    [Google Scholar]
  2. ZhouB. LuY. HajifathalianK. BenthamJ. CesareD.M. DanaeiG. BixbyH. CowanM.J. AliM.K. TaddeiC. LoW.C. SantosR.B. StevensG.A. RileyL.M. MirandaJ.J. BjerregaardP. RiveraJ.A. FouadH.M. MaG. MbanyaJ.C. McGarveyS.T. MohanV. OnatA. PilavA. RamachandranA. RomdhaneH.B. PaciorekC.J. BennettJ.E. EzzatiM. AbdeenZ.A. KadirA.K. RmeilehA.N.M. CazaresA.B. AdamsR. AekplakornW. SalinasA.C.A. AgyemangC. AhmadvandA. OthmanAl.A.R. AlkerwiA. AmouyelP. AmuzuA. AndersenL.B. AnderssenS.A. AnjanaR.M. SkhiriA.H. ArisT. ArlappaN. ArveilerD. AssahF.K. AvdicováM. AziziF. BalakrishnaN. BandoszP. BarbagalloC.M. BarcelóA. BatiehaA.M. BaurL.A. RomdhaneH.B. BenetM. OrtizB.A. BharadwajS. BhargavaS.K. BiY. BjerregaardP. BjertnessE. BjertnessM.B. BjörkelundC. BlokstraA. BoS. BoehmB.O. BoissonnetC.P. BovetP. BrajkovichI. BreckenkampJ. BrennerH. BrewsterL.M. BrianG.R. BrunoG. BuggeA. Cabrera de LeónA. CanG. CândidoA.P. CapuanoV. CarlssonA.C. CarvalhoM.J. CasanuevaF.F. CasasJ.P. CasertaC.A. CastetbonK. ChamukuttanS. ChaturvediN. ChenC.J. ChenF. ChenS. ChengC.Y. ChetritA. ChiouS.T. ChoY. ChudekJ. CifkovaR. ClaessensF. ConcinH. CooperC. CooperR. CostanzoS. CottelD. CowellC. CrujeirasA.B. D’ArrigoG. DallongevilleJ. DanknerR. DauchetL. Gaetanod.G. HenauwD.S. DeepaM. DehghanA. DeschampsV. DhanaK. CastelnuovoD.A.F. DjalaliniaS. DouaK. DrygasW. DuY. DzerveV. EgbagbeE.E. EggertsenR. AtiE.J. ElosuaR. ErasmusR.T. EremC. ErgorG. EriksenL. Escobedo-de la PeñaJ. FallC.H. FarzadfarF. RedondoF.F.J. FergusonT.S. BergésF.D. FerrariM. FerreccioC. FeskensE.J. FinnJ.D. FögerB. FooL.H. ForslundA.S. FouadH.M. FrancisD.K. MdoF.C. FrancoO.H. FronteraG. FurusawaT. GaciongZ. GarnettS.P. GaspozJ.M. GasullM. GatesL. GeleijnseJ.M. GhasemianA. GhimireA. GiampaoliS. GianfagnaF. GiovannelliJ. GiwercmanA. GrossM.G. RivasG.J.P. GorbeaM.B. GottrandF. GrafnetterD. GrodzickiT. GrøntvedA. GrudenG. GuD. GuanO.P. GuerreroR. GuessousI. GuimaraesA.L. GutierrezL. HambletonI.R. HardyR. KumarH.R. HataJ. HeJ. HeidemannC. HerralaS. HihtaniemiI.T. HoS.Y. HoS.C. HofmanA. HormigaC.M. HortaB.L. HoutiL. HowittC. HtayT.T. HtetA.S. HtikeM.M. HuY. HussieniA.S. HuybrechtsI. HwallaN. IacovielloL. IannoneA.G. IbrahimM.M. IkedaN. IkramM.A. IrazolaV.E. IslamM. IwasakiM. JacobsJ.M. JafarT. JamilK.M. JasienskaG. JiangC.Q. JonasJ.B. JoshiP. KafatosA. LeiboviciK.O. KasaeianA. KatzJ. KaurP. KavousiM. KiukaanniemiK.S. KelishadiR. KengneA.P. KerstingM. KhaderY.S. KhaliliD. KhangY.H. KiechlS. KimJ. KolsterenP. KorrovitsP. KratzerW. KromhoutD. KujalaU.M. KulaK. KyobutungiC. LaatikainenT. LachatC. LaidY. LamT.H. LandroveO. LanskaV. LappasG. LaxmaiahA. LeclercqC. LeeJ. LeeJ. LehtimäkiT. LekhrajR. MuñozL.L.M. LiY. LimW.Y. CostaL.M.F. LinH.H. LinX. LissnerL. LorbeerR. LozanoJ.E. LuksieneD. LundqvistA. LytsyP. MaG. CoelhoM.G.L. MachiS. MaggiS. MaglianoD.J. MakdisseM. RaoM.K. ManiosY. ManzatoE. MargozziniP. VidalM.P. MartorellR. MasoodiS.R. MathiesenE.B. MatshaT.E. MbanyaJ.C. McFarlaneS.R. McGarveyS.T. McLachlanS. McNultyB.A. BenchekorM.S. MeirhaegheA. MenezesA.M. MeratS. MeshramI.I. MiJ. MiquelJ.F. MirandaJ.J. MohamedM.K. MohammadK. MohammadifardN. MohanV. YusoffM.M.F. MøllerN.C. MolnárD. MondoC.K. MorejonA. MorenoL.A. MorganK. MoschonisG. MossakowskaM. MostafaA. MotaJ. MottaJ. MuT.T. MuiesanM.L. NurasyidM.M. MursuJ. NagelG. NámešnáJ. NangE.E. NangThetiaV.B. MuñozN.E.M. NdiayeN.C. NenkoI. NerviF. NguyenN.D. NguyenQ.N. MartínezN.R.E. NingG. NinomiyaT. NoaleM. NotoD. NsourM.A. AvilésO.A.M. OhK. OnatA. OrdunezP. OsmondC. OteroJ.A. DaboO.E. PahomovaE. PalmieriL. JonasP.S. PanzaF. ParsaeianM. PeixotoS.V. PelletierC. PeltonenM. PetersA. PeykariN. PhamS.T. PilavA. PitakakaF. PiwonskaA. PiwonskiJ. RubióP.P. PortaM. PortegiesM.L. PoustchiH. PradeepaR. PriceJ.F. PunabM. QasrawiR.F. QorbaniM. RadisauskasR. RahmanM. RaitakariO. RaoS.R. RamachandranA. RamkeJ. RamosR. RampalS. RathmannW. RedonJ. ReganitP.F. RigoF. RobinsonS.M. RobitailleC. ArtalejoR.F. Rodriguez-Perez MdelC. VillamizarR.L.A. MartinezR.R. RonkainenK. RosengrenA. RubinsteinA. RuiO. BetancourtR.B.S. HorimotoR.R.V. RutkowskiM. SabanayagamC. SachdevH.S. SaidiO. SakaryaS. SalanaveB. SalonenJ.T. SalvettiM. AbantoS.J. SantosD. Santosd.R.N. SantosR. SaramiesJ.L. SardinhaL.B. SarrafzadeganN. SaumK.U. ScazufcaM. SchargrodskyH. NaveS.C. SeinA.A. SharmaS.K. ShawJ.E. ShibuyaK. ShinY. ShiriR. SiantarR. SibaiA.M. SimonM. SimonsJ. SimonsL.A. SjostromM. HilczerS.J. SlusarczykP. SmeethL. SnijderM.B. SoH.K. SobngwiE. SöderbergS. SolfrizziV. SonestedtE. SoumareA. StaessenJ.A. StathopoulouM.G. JohannessenS.J. StehleP. SteinA.D. StessmanJ. StöcklD. StokwiszewskiJ. StronksK. StrufaldiM.W. SunC.A. SundströmJ. SungY.T. SuriyawongpaisalP. SyR.G. TaiE.S. TamosiunasA. TangL. TarawnehM. MamaniT.C.B. TaylorA. TheobaldH. ThijsL. ThuesenB.H. TolonenH.K. TolstrupJ.S. TopbasM. TorrentM. TraissacP. TrinhO.T. ReidT.M.K. TuomainenT.P. TurleyM.L. TzourioC. UedaP. UkoliF.A. UlmerH. UusitaloH.M. ValdiviaG. ValviD. Rossemv.L. Valkengoedv.I.G. VanderschuerenD. VanuzzoD. VegaT. MelendezV.G. VeronesiG. VerschurenW.M. VerstraetenR. VietL. VioqueJ. VirtanenJ.K. SiestV.S. ViswanathanB. VollenweiderP. VoutilainenS. VrijheidM. WadeA.N. WagnerA. WaltonJ. MohamudW.W.N. WangF. WangM.D. WangQ. WangY.X. WannametheeS.G. WeerasekeraD. WhincupP.H. WidhalmK. WiecekA. WijgaA.H. WilksR.J. WilleitJ. WilsgaardT. WojtyniakB. WongT.Y. WooJ. WoodwardM. WuF.C. WuS.L. XuH. YanW. YangX. YeX. YoshiharaA. ColemanY.N.O. ZambonS. ZargarA.H. ZdrojewskiT. ZhaoW. ZhengY. CisnerosJ.J. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4·4 million participants.Lancet2016387100271513153010.1016/S0140‑6736(16)00618‑827061677
    [Google Scholar]
  3. IDF Diabetes Atlas.9th Ed.Bagsværd, DenmarkInternational Diabetes Federation2019
    [Google Scholar]
  4. RahimlouM. MirzaeiK. KeshavarzS.A. nezhadH.A. Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals.Diabetes Metab. Syndr.2016101Suppl. 1S60S6510.1016/j.dsx.2015.09.01526482964
    [Google Scholar]
  5. BakhtiaryM. MorvaridzadehM. AgahS. RahimlouM. ChristopherE. ZadroJ.R. HeshmatiJ. Effect of probiotic, prebiotic, and synbiotic supplementation on cardiometabolic and oxidative stress parameters in patients with chronic kidney disease: A systematic review and meta-analysis.Clin. Ther.2021433e71e9610.1016/j.clinthera.2020.12.02133526314
    [Google Scholar]
  6. ZhangZ.Y. MiaoL.F. QianL.L. WangN. QiM.M. ZhangY.M. DangS.P. WuY. WangR.X. Molecular mechanisms of glucose fluctuations on diabetic complications.Front. Endocrinol.20191064010.3389/fendo.2019.0064031620092
    [Google Scholar]
  7. ShieldsH.J. TraaA. RaamsdonkV.J.M. Beneficial and detrimental effects of reactive oxygen species on lifespan: A comprehensive review of comparative and experimental studies.Front. Cell Dev. Biol.2021962815710.3389/fcell.2021.62815733644065
    [Google Scholar]
  8. HalimM. HalimA. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes).Diabetes Metab. Syndr.20191321165117210.1016/j.dsx.2019.01.04031336460
    [Google Scholar]
  9. SharmaA. MittalS. AggarwalR. ChauhanM.K. Diabetes and cardiovascular disease: Inter-relation of risk factors and treatment.Future J. Pharm. Sci.20206113010.1186/s43094‑020‑00151‑w
    [Google Scholar]
  10. AlkadiH. A review on free radicals and antioxidants.Infect. Disord. Drug Targets2020201162610.2174/22123989OTEznMzIwTcVY29952268
    [Google Scholar]
  11. ZhengY. LeyS.H. HuF.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.Nat. Rev. Endocrinol.2018142889810.1038/nrendo.2017.15129219149
    [Google Scholar]
  12. KuchelmeisterF van de GeerS Finite sample rates for logistic regression with small noise or few samples.arXiv:2305.1599120241610.1007/s13171‑024‑00358‑6
    [Google Scholar]
  13. RodgersJ.L. JonesJ. BolledduS.I. VanthenapalliS. RodgersL.E. ShahK. KariaK. PanguluriS.K. Cardiovascular risks associated with gender and aging.J. Cardiovasc. Dev. Dis.2019621910.3390/jcdd602001931035613
    [Google Scholar]
  14. TramuntB. SmatiS. GrandgeorgeN. LenfantF. ArnalJ.F. MontagnerA. GourdyP. Sex differences in metabolic regulation and diabetes susceptibility.Diabetologia202063345346110.1007/s00125‑019‑05040‑331754750
    [Google Scholar]
  15. AwadiA.F. HassaneinM. HussainH.Y. Prevalence of diabetes and associated health risk factors among adults in dubai, united arab emirates: Results from dubai household survey 2019.DOAJ2021264164173
    [Google Scholar]
  16. SulaimanN. MahmoudI. HusseinA. ElbadawiS. AbusnanaS. ZimmetP. ShawJ. Diabetes risk score in the united arab emirates: A screening tool for the early detection of type 2 diabetes mellitus.BMJ Open Diabetes Res. Care201861e00048910.1136/bmjdrc‑2017‑00048929629178
    [Google Scholar]
  17. NordströmA. HadréviJ. OlssonT. FranksP.W. NordströmP. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass.J. Clin. Endocrinol. Metab.2016101103740374610.1210/jc.2016‑191527490920
    [Google Scholar]
  18. AamirA.H. HaqU.Z. MaharS.A. QureshiF.M. AhmadI. JawaA. SheikhA. RazaA. FazidS. JadoonZ. IshtiaqO. SafdarN. AfridiH. HealdA.H. Diabetes prevalence survey of Pakistan (dps-pak): Prevalence of type 2 diabetes mellitus and prediabetes using hba1c: A population-based survey from pakistan.BMJ Open201992e02530010.1136/bmjopen‑2018‑02530030796126
    [Google Scholar]
  19. GatineauM. HancockC. HolmanN. Adult obesity and type 2 diabetes.Public HealthEngland2014514
    [Google Scholar]
  20. Center, Dubai Statistics. Number of population estimated by nationality-emirate of dubai.2017Available from: https://www.dsc.gov.ae/Report/DSC_SYB_2017_01%20_%2003.pdf
  21. HamoudiR. Saheb Sharif-AskariN. Saheb Sharif-AskariF. AbusnanaS. AljaibejiH. TaneeraJ. SulaimanN. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates.Sci. Rep.2019911743710.1038/s41598‑019‑53505‑731767874
    [Google Scholar]
  22. AsiimweD. MautiG.O. KiconcoR. Prevalence and risk factors associated with type 2 diabetes in elderly patients aged 45-80 years at Kanungu District.J. Diabetes Res.2020202011510.1155/2020/5152146
    [Google Scholar]
  23. KumarK.N. KatkuriS. RamyacharithaI. A study to assess prevalence of diabetes mellitus and its associated risk factors among adult residents of rural Khammam.IJCMPH20185413601365
    [Google Scholar]
  24. BasitA. FawwadA. QureshiH. SheraA.S. Prevalence of diabetes, pre-diabetes and associated risk factors: Second National Diabetes Survey of Pakistan (NDSP), 2016–2017.BMJ Open201888e02096110.1136/bmjopen‑2017‑02096130082350
    [Google Scholar]
  25. ThakurS.K. DhakalS.P. ParajuliS. SahA.K. NepalS.P. PaudelB.D. Microalbuminuria and its risk factors in type 2 diabetic patients.J. Nepal Health Res. Counc.2019171616510.33314/jnhrc.v17i01.162031110390
    [Google Scholar]
  26. TangvarasittichaiS. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.World J. Diabetes20156345648010.4239/wjd.v6.i3.45625897356
    [Google Scholar]
  27. GriendlingK.K. CamargoL.L. RiosF.J. LopesA.R. MontezanoA.C. TouyzR.M. Oxidative stress and hypertension.Circ. Res.20211287993102010.1161/CIRCRESAHA.121.31806333793335
    [Google Scholar]
  28. CruzG.M. VeraM.I. CañetasC.T.E. ChanC.Y. TorresN. TovarA.R. MotaM.C. GómezT.J.M. MonterP.C. LugoR. SolisG.A.L. NavaA.A. Chaya leaf decreased triglycerides and improved oxidative stress in subjects with dyslipidemia.Front. Nutr.2021866624310.3389/fnut.2021.66624334368206
    [Google Scholar]
  29. RajeshwariA. DivijaD.A. SomshekharG.N. Study of serum sialic acid, microalbuminuria, oxidative stress and antioxidant status in diabetic nephropathy.IJBB20191511725
    [Google Scholar]
  30. AslanM. SabuncuT. KocyigitA. CelikH. SelekS. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients.Nutr. Metab. Cardiovasc. Dis.2007171073474010.1016/j.numecd.2006.08.00517321120
    [Google Scholar]
  31. KharroubiA.T. DarwishH.M. AkkawiM.A. AshareefA.A. AlmasriZ.A. BaderK.A. KhammashU.M. Total antioxidant status in type 2 diabetic patients in palestine.J. Diabetes Res.201520151710.1155/2015/46127126090472
    [Google Scholar]
  32. NajafiA. PourfarzamM. ZadhoushF. Oxidant/antioxidant status in type-2 diabetes mellitus patients with metabolic syndrome.J. Res. Med. Sci.2021261610.4103/jrms.JRMS_249_2034084185
    [Google Scholar]
  33. LimS. BarterP. Antioxidant effects of statins in the management of cardiometabolic disorders.J. Atheroscler. Thromb.20142110997101010.5551/jat.2439825132378
    [Google Scholar]
  34. GermanC.A. LiaoJ.K. Understanding the molecular mechanisms of statin pleiotropic effects.Arch. Toxicol.20239761529154510.1007/s00204‑023‑03492‑637084080
    [Google Scholar]
  35. KurajohM. FukumotoS. YoshidaS. AkariS. MuraseT. NakamuraT. IshiiH. YoshidaH. NagataY. MoriokaT. MoriK. ImanishiY. HirataK. EmotoM. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry.Sci. Rep.2021111737810.1038/s41598‑021‑86962‑033795813
    [Google Scholar]
  36. IndrianiV. LestariT. DewantariV. Duration of diabetes as an important risk factor of microalbuminuria in type 2 diabetes.Universa Medicina2020391424610.18051/UnivMed.2020.v39.42‑46
    [Google Scholar]
  37. SaleemT. DahpyM. EzzatG. AbdelrahmanG. AzizA.E. FarghalyR. The profile of plasma free amino acids in type 2 diabetes mellitus with insulin resistance: Association with microalbuminuria and macroalbuminuria.Appl. Biochem. Biotechnol.2019188385486710.1007/s12010‑019‑02956‑930706418
    [Google Scholar]
  38. OgunmuyiwaO. Hypertension and diabetes comorbidity: Factors that are associated with their joint occurrence.Doctoral dissertation, ThesisGeorgia State University2023
    [Google Scholar]
  39. NicolaP. ArdeleanuE. GadauC. DorobantuM. DarabontR. TileaI. VargaA. FolescuR. ZamfirA.S. BoancaM. StratL. BaajT. GurgusD. Evaluation of biochemical and clinical parametres of hypertension with type 2 diabetes mellitus.Revista de Chimie20186992402240610.37358/RC.18.9.6542
    [Google Scholar]
  40. KhanZ.K. MajeedA. RashidA. The risk factors associated with diabetic dyslipidemia and anthropometric parameters linked with and without dyslipidemia in type 2 diabetes mellitus.PAFMJ2020702628633
    [Google Scholar]
/content/journals/cdr/10.2174/0115733998336940241219182916
Loading
/content/journals/cdr/10.2174/0115733998336940241219182916
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test